The global cholera vaccines market size reached US$ 5.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Million by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032. More Info:- https://www.imarcgroup.com/cholera-vaccines-market

1. Global Cholera Vaccines
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Cholera Vaccines
Market: Global Industry Trends, Share, Size, Growth, Opportunity and
Forecast 2024-2032," the global cholera vaccines market size reached US$
5.4 Million in 2023.
Cholera is an acute intestinal disease that is generally caused by the
consumption of contaminated water and food. It is spread by the Vibrio
Cholerae bacteria that leads to pain in the abdomen, diarrhea, nausea,
vomiting and water-electrolyte imbalance.
Cholera vaccines are effective in stimulating the production of antibodies that
aid in preventing the disease among individuals. W idely prepared using the live
cholera-causing bacteria to aid in developing immunity against the same, these
vaccines are directly injected intramuscularly or intradermally in the body.
Request for a PDF sample of this report:
https://www.imarcgroup.com/cholera -vaccines-market/requestsample

4. Report Description
Global Cholera Vaccines Market Trends:
The global market is primarily driven by the escalating prevalence of cholera among the masses. This can be
attributed to the poor sanitation and hygiene conditions in rural and geographically extended areas. Moreover, the
rising awareness regarding the availability of cholera vaccines among the masses has propelled the product
demand. In line with this, numerous initiatives undertaken by several government agencies and non-government
organizations (NGOs) across multiple countries for conducting immunization programs are providing a boost to
the demand for cholera vaccines.
Along with this, the increasing investments and funding by public and private agencies for conducting extensive
research and development (R&D) activities are favorably impacting the market. Other factors, including the
expanding healthcare expenditure, a considerable increase in water pollution levels, and the rising number of
research laboratories and diagnosis centers, are also positively influencing the market growth.
Looking forward, the market is anticipated to reach a value of US$ 13.0 Million by 2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/cholera-vaccines-market

5. Report
Segmentation
Breakup by Vaccine Type:
• Whole Cell V. Cholerae O1 with Recombinant B -
Subunit
• Killed Oral O1 and O139
Breakup by Product:
• Dukoral
• Shanchol
• Vaxchora
• Euvichol and Euvichol-Plus
• Others
Breakup by End User:
• Hospitals and Clinics

6. Report
Segmentation
• Research and Academic Laboratories
• Others
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Astellas Pharma Inc.
• Celldex Therapeutics Inc. (Avant
Immunotherapeutics Inc.)
• Emergent BioSolutions Inc.
• Eubiologics Co. Ltd.
• Johnson & Johnson
• Merck & Co. Inc.
• Pfizer Inc.
• PharmaChoice Canada Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Valneva SE

8. Key Questions
Answered in
the Report
What was the size of the global cholera vaccines market in
2023?
What is the expected growth rate of the global cholera
vaccines market during 2024-2032?
What are the key factors driving the global cholera vaccines
market?
What has been the impact of COVID-19 on the global cholera
vaccines market?
What is the breakup of the global cholera vaccines market
based on the vaccine type?
What is the breakup of the global cholera vaccines market
based on the product?
What is the breakup of the global cholera vaccines market
based on the end user?
What are the key regions in the global cholera vaccines
market?
Who are the key players/companies in the global cholera
vaccines market?

9. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cholera Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 W hole Cell V. Cholerae O1 with Recombinant B -
Subunit
6.1.1 Mark et Trends
6.1.2 Mark et Forecast
6.2 Killed Oral O1 and O139
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
7 Market Breakup by Product
7.1 Duk oral
7.1.1 Mark et Trends
7.1.2 Mark et Forecast

10. Table of
Contents
7.2 Shanchol
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
7.3 Vaxchora
7.3.1 Mark et Trends
7.3.2 Mark et Forecast
7.4 Euvichol and Euvichol-Plus
7.4.1 Mark et Trends
7.4.2 Mark et Forecast
7.5 Others
7.5.1 Mark et Trends
7.5.2 Mark et Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 Research and Academic Laboratories
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
8.3 Others
8.3.1 Mark et Trends
8.3.2 Mark et Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Mark et Forecast
9.1.2 Canada
9.1.2.1 Mark et Trends
9.1.2.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/cholera -vaccines-market/toc

11. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

12. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com